Total Funding
68
51
Total FundingGrant raised
Growth Score 68 in past quarter
-4 pts
Heat Score 51 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
89178
Ciloa is a uniquely positioned to support your projects aiming to create new therapeutic.
- Mealy KONG: CFO
- Robert MAMOUN: CEO
About the Company
Ciloa is the only one allowing to produce all types of membrane proteins with their native conformation on exosomes. It allows to load exosomes with cytosolic proteins as well. It thus makes it possible to reach the most difficult families of membrane protein targets, known as “undruggable”, some being the most promising for therapies.Ciloa takes
advantage of the natural properties of exosomes; they are natural immuno-stimulators, biocompatible, intercellular membrane messengers, and able to cross all the human body barriers including the blood-brain barrier.